Eastern Bank’s Artiva Biotherapeutics ARTV Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTV
Eastern Bank's ARTV Position: Q3 2026 in Review
Eastern Bank opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 155 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings.
3 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.
- Eastern Bank held 155 shares of Artiva Biotherapeutics worth $1.1K as of Q3 2026.
- Artiva Biotherapeutics was a new Eastern Bank position in Q3 2026.
- Artiva Biotherapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1060 holding.
- 3 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.
Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.